Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma of Kidney”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07018037
What this trial is testing

Role of TTV During First-line Immunotherapy Treatment in Patients With Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Regina Elena Cancer Institute 20
Not applicableStudy completedNCT05168761
What this trial is testing

Complications Associated With Partial Nephrectomy for Renal Cancer

Who this might be right for
Renal CancerPartial Nephrectomy
Central Hospital, Nancy, France 7,664
Testing effectiveness (Phase 2)UnknownNCT00293501
What this trial is testing

Tinzaparin in Treating Patients With Metastatic Kidney Cancer That Cannot Be Removed By Surgery

Who this might be right for
Kidney Cancer
University of Vermont 35
Testing effectiveness (Phase 2)Looking for participantsNCT07172386
What this trial is testing

Preoperative Therapy of Super-selective Tumor Artery Embolization Combined With Toripalimab and Axitinib in Advanced RCC

Who this might be right for
Renal Cell Carcinoma (RCC)
Tianjin Medical University Second Hospital 40
Early research (Phase 1)Study completedNCT00283075
What this trial is testing

Mouse Cancer Cell-containing Macrobeads in the Treatment of Human Cancer

Who this might be right for
Intraabdominal Cancers (Various Types)
The Rogosin Institute 56
Not applicableStudy completedNCT05729763
What this trial is testing

Three-dimensional Virtual Imaging to Improve the Accuracy of Standard CT-based Nephrometric Scores: a Prospective Multicentric Observational Study

Who this might be right for
Kidney NeoplasmsCarcinoma, Renal Cell
San Luigi Gonzaga Hospital 300
Not applicableActive Not RecruitingNCT05820087
What this trial is testing

The HistoSonics Edison™ System for Treatment of Primary Solid Renal Tumors Using Histotripsy (#HOPE4KIDNEY)

Who this might be right for
Renal CancerTumor, SolidKidney Cancer+2 more
HistoSonics, Inc. 67
Not applicableStudy completedNCT04076787
What this trial is testing

Clinical Outcomes for Patients With Renal Cell Carcinoma Who Received First-Line Sunitinib

Who this might be right for
Metastatic Renal Cell Carcinoma
Pfizer 1,769
Testing effectiveness (Phase 2)Looking for participantsNCT07397611
What this trial is testing

Pre-NEOSHIFT-RCC: Neoadjuvant HIF-Inhibitor Immunotherapy in RCC

Who this might be right for
Renal Cell CarcinomaKidney CancerKidney Neoplasm+1 more
Dana-Farber Cancer Institute 32
Testing effectiveness (Phase 2)Study completedNCT02440334
What this trial is testing

Two and Three Dimensional Contrast-enhanced Ultrasound for Screening of Renal Cell Carcinoma Recurrence Following Cryoablation

Who this might be right for
Renal Cell Carcinoma
Thomas Jefferson University 53
Not applicableEnded earlyNCT01599832
What this trial is testing

Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Measuring Effects of Pazopanib Hydrochloride in Patients With Metastatic Kidney Cancer

Who this might be right for
Clear Cell Renal Cell CarcinomaRecurrent Renal Cell CancerStage IV Renal Cell Cancer
University of Chicago 20
Not applicableStudy completedNCT03955393
What this trial is testing

FAZA PET IMAGING IN DETECTING LYMPH NODE METASTASES IN RENAL CELL CARCINOMA PATIENTS

Who this might be right for
Renal Cell Carcinoma (RCC)
IRCCS San Raffaele 20
Not applicableWithdrawnNCT02928263
What this trial is testing

Healthcare Cost and Resource Utilization Related to Metastatic Renal Cell Carcinoma Treatment With Intravenous and Oral Agents

Who this might be right for
Renal Cell Carcinoma
Bristol-Myers Squibb
Not applicableLooking for participantsNCT05363657
What this trial is testing

International REgistry of COnservative or Radical Treatment of Localized Kidney Tumors

Who this might be right for
Kidney Cancer
Azienda Ospedaliero-Universitaria Careggi 10,000
Testing effectiveness (Phase 2)Ended earlyNCT03829501
What this trial is testing

A Phase 1/2, Open-label, Multi-center Study of the Safety and Efficacy of Alomfilimab (KY1044) as Single Agent and in Combination With Anti-PD-L1 (Atezolizumab) in Adult Patients With Selected Advanced Malignancies

Who this might be right for
Squamous Cell Carcinoma of Head and NeckNon-small Cell Lung CancerHepatocellular Carcinoma+9 more
Kymab Limited 222
Testing effectiveness (Phase 2)Study completedNCT03012581
What this trial is testing

Secured Access to Nivolumab for Adult Patients With Selected Rare Cancer Types

Who this might be right for
Carcinoma, Renal CellHead and Neck NeoplasmSkin Neoplasms+3 more
UNICANCER 269
Not applicableNot Yet RecruitingNCT06032728
What this trial is testing

Multimodal Recurrence Scoring System for Stratifying Stage III Clear Cell Renal Cell Carcinoma of Receiving Adjuvant Treatment

Who this might be right for
Renal Cell Carcinoma
First Affiliated Hospital, Sun Yat-Sen University 488
Testing effectiveness (Phase 2)Ended earlyNCT03165721
What this trial is testing

A Phase II Trial of the DNA Methyl Transferase Inhibitor, Guadecitabine (SGI-110), in Children and Adults With Wild Type GIST,Pheochromocytoma and Paraganglioma Associated With Succinate Dehydrogenase Deficiency and HLRCC-associated Kidney Cancer

Who this might be right for
ParagangliomaGastrointestinal Stromal TumorsCarcinoma, Renal Cell+2 more
National Cancer Institute (NCI) 9
Not applicableStudy completedNCT00513175
What this trial is testing

Non-Myeloablative Allogeneic Stem Cell Transplantation With Matched Unrelated Donors for Treatment of Hematologic Malignancies, Renal Cell Carcinoma, and Aplastic Anemia

Who this might be right for
Acute Myeloid LeukemiaMyelodysplasiaAcute Lymphoblastic Leukemia+8 more
University of California, San Francisco 44
Early research (Phase 1)Ended earlyNCT02212730
What this trial is testing

A Study Evaluating the Effect of Pembrolizumab (MK-3475) in Participants With Renal Cell Cancer (MK-3475-031)

Who this might be right for
Renal Cell Cancer
Merck Sharp & Dohme LLC 10
Next Page